Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Iteos Therapeutics Inc stock

Learn how to easily invest in Iteos Therapeutics Inc stock.

Iteos Therapeutics Inc is a biotechnology business based in the US. Iteos Therapeutics Inc shares (ITOS) are listed on the NASDAQ and all prices are listed in US Dollars. Iteos Therapeutics Inc employs 94 staff and has a trailing 12-month revenue of around $539 million.

How to buy shares in Iteos Therapeutics Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ITOS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Iteos Therapeutics Inc stock price (NASDAQ: ITOS)

Use our graph to track the performance of ITOS stocks over time.

Iteos Therapeutics Inc shares at a glance

Information last updated 2022-09-25.
Latest market close$18.87
52-week range$16.21 - $52.43
50-day moving average $23.46
200-day moving average $29.09
Wall St. target price$48.00
PE ratio 2.1718
Dividend yield $0 (0%)
Earnings per share (TTM) $8.79

Buy Iteos Therapeutics Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Iteos Therapeutics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Iteos Therapeutics Inc price performance over time

Historical closes compared with the close of $18.87 from 2022-09-29

1 week (2022-09-21) -3.33%
1 month (2022-09-01) -21.18%
3 months (2022-07-01) -9.58%
6 months (2022-03-28) N/A
1 year (2021-10-01) -30.14%
2 years (2020-10-01) -22.98%
3 years (2019-09-27) N/A
5 years (2017-09-27) N/A

Is Iteos Therapeutics Inc stock undervalued or overvalued?

Valuing Iteos Therapeutics Inc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Iteos Therapeutics Inc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Iteos Therapeutics Inc's P/E ratio

Iteos Therapeutics Inc's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Iteos Therapeutics Inc shares trade at around 2x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Iteos Therapeutics Inc's EBITDA

Iteos Therapeutics Inc's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $418.2 million.

The EBITDA is a measure of a Iteos Therapeutics Inc's overall financial performance and is widely used to measure a its profitability.

Iteos Therapeutics Inc financials

Revenue TTM $539 million
Operating margin TTM 77.46%
Gross profit TTM $344.8 million
Return on assets TTM 46.04%
Return on equity TTM 71.15%
Profit margin 61.17%
Book value $17.91
Market capitalisation $679.1 million

TTM: trailing 12 months

Iteos Therapeutics Inc share dividends

We're not expecting Iteos Therapeutics Inc to pay a dividend over the next 12 months.

Iteos Therapeutics Inc share price volatility

Over the last 12 months, Iteos Therapeutics Inc's shares have ranged in value from as little as $16.21 up to $52.43. A popular way to gauge a stock's volatility is its "beta".

ITOS.US volatility(beta: 1.53)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Iteos Therapeutics Inc's is 1.534. This would suggest that Iteos Therapeutics Inc's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Iteos Therapeutics Inc overview

Iteos Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc"R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts. .

Frequently asked questions

What percentage of Iteos Therapeutics Inc is owned by insiders or institutions?
Currently 0.266% of Iteos Therapeutics Inc shares are held by insiders and 109.524% by institutions.
How many people work for Iteos Therapeutics Inc?
Latest data suggests 94 work at Iteos Therapeutics Inc.
When does the fiscal year end for Iteos Therapeutics Inc?
Iteos Therapeutics Inc's fiscal year ends in December.
Where is Iteos Therapeutics Inc based?
Iteos Therapeutics Inc's address is: 321 Arsenal Street, Cambridge, MA, United States, 02472-5710
What is Iteos Therapeutics Inc's ISIN number?
Iteos Therapeutics Inc's international securities identification number is: US46565G1040

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site